-
Letter
-
United StatesBiotech or pharma, therapeutic R&D
-
-
United StatesVC/Corporate VC
-
United StatesVC/Corporate VC
-
Biotech or pharma, therapeutic R&D
-
United StatesBiotech or pharma, therapeutic R&D
-
United StatesBiotech or pharma, therapeutic R&D
-
VC/Corporate VC
-
United StatesOther products or services
-
JapanBiotech or pharma, therapeutic R&D
-
United KingdomBiotech or pharma, therapeutic R&DIT, informationOther R&D services
-
United StatesVC/Corporate VC
-
United StatesBiotech or pharma, therapeutic R&D
-
ChinaBiotech or pharma, therapeutic R&D
-
Investor (buy-side or sell-side research)VC/Corporate VC
-
United StatesBiotech or pharma, therapeutic R&D
-
United StatesDigital health
-
United StatesVC/Corporate VC
-
VC/Corporate VC
-
South KoreaBiotech or pharma, therapeutic R&D
-
ChinaBiotech or pharma, therapeutic R&D
-
CMO, CRO
-
United States
-
United StatesBiotech or pharma, therapeutic R&D
-
South KoreaBiotech or pharma, therapeutic R&DDiagnosticsDigital healthMedical device or technology
-
ChinaBiotech or pharma, therapeutic R&D
-
United StatesBiotech or pharma, animal healthBiotech or pharma, therapeutic R&D
-
Angel Investing
-
United StatesBiotech or pharma, therapeutic R&D
-
United StatesVC/Corporate VC
-
United StatesRoyalty/Debt Financing
-
United StatesRoyalty/Debt Financing
-
VC/Corporate VC
-
United StatesRoyalty/Debt Financing
-
Investor (buy-side or sell-side research)
-
DenmarkBiotech or pharma, animal healthBiotech or pharma, therapeutic R&D
-
Biotech or pharma, therapeutic R&D
-
FranceBiotech or pharma, therapeutic R&D
-
Biotech or pharma, therapeutic R&D
-
United StatesVC/Corporate VC
-
United StatesRoyalty/Debt Financing
-
GermanyBiotech or pharma, therapeutic R&D
-
United StatesBiotech or pharma, therapeutic R&D